BioTrack Capital logo

BioTrack Capital

Asia, Shanghai, China, Shanghai

Description

BioTrack Capital is a China-based investment firm.

Investor Profile

BioTrack Capital has backed more than 16 startups, with 7 new investments in the last 12 months alone. The firm has led 4 rounds, about 25% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Health Care, Biotechnology, Medical.
  • Led 3 rounds in the past year.

Stage Focus

  • Series B (50%)
  • Series A (25%)
  • Series C (6%)
  • Series F (6%)
  • Angel (6%)
  • Seed (6%)

Country Focus

  • China (75%)
  • United States (19%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Product Research
  • Manufacturing
  • Medical Device
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BioTrack Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 5
Daehwa Pharmaceutical
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Boyuan Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
LongRiver Investments
Asia, Shanghai, China, Xuhui
Co-Investments: 2
CSPC Pharmaceutical Group
Asia, Hebei, China, Shijiazhuang
Co-Investments: 2
CASVC
Asia, Beijing, China, Beijing
Co-Investments: 1
Atlas Capital LLC
North America, Arizona, United States, Phoenix
Co-Investments: 1
HC
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Yingke Capital
Asia, Jiangxi, China, Fuzhou
Co-Investments: 2

What are some of recent deals done by BioTrack Capital?

Oukejian

Nanshan, Hunan, China

Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases.

BiotechnologyHealth CareMedical
Series BDec 16, 2025
Amount Raised: $30,000,000
KYinno

Beijing, Beijing, China

KYinno is a drug development company that is dedicated to oncology drug development with a focus on immune treatments against cancer.

BiotechnologyHealth CareMedicalOncology
Series BDec 15, 2025
Amount Raised: $35,457,472
BlossomHill Therapeutics

San Diego, California, United States

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

BiopharmaBiotechnologyHealth CareOncologyPharmaceuticalTherapeutics
Series BDec 10, 2025
Amount Raised: $84,000,000
AnyiPu

Suzhou, Jiangsu, China

AnyiPu is a leading Chinese high-tech company focused on chemical analysis and medical testing instruments.

ManufacturingSales
Series BDec 5, 2025
Amount Raised: $14,144,072
Microlon Biotechnology

Chengdu, Sichuan, China

Microlon Biotechnology is an innovative high-tech company that specializes in microfluidic intelligent manufacturing technologies.

BiotechnologyManufacturingMedicalMedical Device
SeedNov 21, 2025
Rapafusyn Pharmaceuticals

Baltimore, Maryland, United States

Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle.

Biotechnology
Series ASep 4, 2025
Amount Raised: $16,000,000
Minghui Pharmaceutical

Shanghai, Shanghai, China

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

BiopharmaBiotechnologyMedicalPharmaceuticalProduct ResearchTherapeutics
Series UnknownAug 7, 2025
Amount Raised: $131,000,000

Cavan Auto specializes in the production of electric vehicles and hydrogen fuel cell-powered new energy.

AutomotiveElectric Vehicle
SeedJun 30, 2025
Amount Raised: $167,501,849
Spurious

Shanghai, Shanghai, China

Spurious is the developer of the small molecule anti-tumordrug developers.

Health Care
AngelJun 4, 2025
Amount Raised: $27,834,994
Sirius Therapeutics

San Diego, California, United States

Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BMay 9, 2025
Amount Raised: $50,000,000

Find More Investors Like BioTrack Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

BioTrack Capital | Pipeseed